Lowering serum uric acid levels may contribute to renoprotective benefits of SGLT2-Is as well as cardiovascular benefits, since elevated uric acid has been associated with hypertension and MACE [19]. The gene discussed is SLC5A2; the disease is hypertensive disorder.